1. Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody. (31st December 2022) Authors: Weaver, Jessica D.; Stack, Edward C.; Buggé, Joshua A.; Hu, Changyun; McGrath, Lara; Mueller, Amy; Wong, Masie; Klebanov, Boris; Rahman, Tanzila; Kaufman, Rosemary; Fregeau, Christine; Spaulding, Vikki; Priess, Michelle; Legendre, Kristen; Jaffe, Sarah; Upadhyay, Dhruvkumar; Singh, Anirudh; Xu, C... Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗